Health conditions associated with aging and end of life of adults with Down syndrome
about
Medicine in stamps: history of Down syndrome through philatelySleep and sleep disorders in rare hereditary diseases: a reminder for the pediatrician, pediatric and adult neurologist, general practitioner, and sleep specialistNeurological phenotypes for Down syndrome across the life spanAlzheimer's Disease in Down Syndrome.Sleep problems and associated comorbidities among adults with Down syndromeMeta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processesValidation and application of health utilities index in Chinese subjects with down syndrome.Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice.Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).Ophthalmic disorders in adults with down syndrome.Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.Adaptive downregulation of mitochondrial function in down syndromeCerebrovascular contributions to aging and Alzheimer's disease in Down syndrome."Intellectual developmental disorders": reflections on the international consensus document for redefining "mental retardation-intellectual disability" in ICD-11.Event-related potential index of age-related differences in memory processes in adults with Down syndrome.Validation of Evidence-Based Fall Prevention Programs for Adults with Intellectual and/or Developmental Disorders: A Modified Otago Exercise Program.Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis.Atypical aging in Down syndrome.Pharmacotherapeutic Considerations for Individuals with Down Syndrome.Outcome Measures for Clinical Trials in Down Syndrome.Epidemiology of estrogen and dementia in women with Down syndrome.Leisure Activity and Caregiver Involvement in Middle-Aged and Older Adults With Down Syndrome.Stem cells: Down's syndrome link to ageing.Increased levels of plasma total tau in adult Down syndrome.High prevalence of diabetes mellitus, hypertension and obesity among persons with a recorded diagnosis of intellectual disability or autism spectrum disorder.Analysis of Taurine's Anti-Down Syndrome Potential in Caenorhabditis elegans.Adaptive behaviour, executive function and employment in adults with Down syndrome.Down Syndrome, Obesity, Alzheimer's Disease, and Cancer: A Brief Review and Hypothesis.Co-occurring medical conditions in adults with Down syndrome: A systematic review toward the development of health care guidelines.Kidney Transplant Outcomes in 2 Adults With Down Syndrome.Hospitalizations among people with Down syndrome: a nationwide population-based study in DenmarkUsing machine learning to identify patterns of lifetime health problems in decedents with autism spectrum disorder
P2860
Q27013924-8C68FF9D-91EF-4139-B86C-CC4371AE753EQ27015026-5B5B8630-BE9D-4A31-A11B-E769F650C89CQ27025698-246FE480-CED0-4C89-9E86-FC4ACE5C1115Q30857550-9A082EDD-7C22-47FA-9E41-6D364C966BE6Q33655518-09AF161E-9461-469E-BD40-1A80EE447654Q33898516-DD26A2DB-5EC2-428F-B0EC-A6DBAC5903BEQ34396326-3E80CCC6-5D1F-49BD-A19B-9021C048B9D4Q34514070-B8CD8E51-DCED-4B0A-BF05-2DEBB9D8F719Q34979826-8842657D-A00A-4DEF-8D93-0DA8F9D09387Q35915355-EEF1391B-88A5-4127-B4E7-7AEBD633A1F6Q36522425-DF5A0C75-C396-47F3-B518-05BC1502F8A8Q36632280-B56196F8-E50D-4C16-9FF0-F81FC237ADB6Q36767734-18A23033-BE98-442A-BA8A-D16C7A0BFA2AQ36771085-F8CE9E5C-BC10-4835-8D97-AA7150A1744AQ37362095-6BF9C306-30DF-4FAE-AAF7-A394A263AABDQ37475129-4469A58D-E766-402D-87FF-57AB8EDAC94AQ38129323-20D7C85E-1215-4CA7-AA2E-6E9E2C4C66A9Q38129325-9F1F94F1-00EF-4749-9583-B59A98BAF4A2Q39032991-EE9154B1-F6EB-497C-A4B9-562B672ED45DQ39269317-E7BFDC46-03B9-470A-9A8A-EDDF2488ABE9Q40069328-E4DB6035-EB2B-498D-98C0-BC93F04C0809Q41586931-6C569BDC-CE64-4128-8A93-DC8214239608Q45346713-6613F35C-2EF3-457E-AE71-1AA8316F752FQ47143134-A7B025D0-C3D9-4D77-8930-9D50496B99E9Q47245212-29614FDB-2990-4832-AC3D-BF72F78B70CAQ47890126-0ECC22D1-C897-43E0-B1D1-E6AE0CE332FBQ48162189-81AE9C23-8F58-45EF-A4E9-B14421B0392AQ52340254-FA1B22F3-3D24-4434-8B65-32EE86B454BFQ52438040-BF839CC4-09F5-4BCC-B187-8643F871F28CQ55509826-BA6BFA9D-B1E4-4856-B242-1CB36D877977Q57386642-51C3449C-A00A-4A68-B9D9-26EE97F50439Q58685458-AE185758-E4CA-4A76-B335-A595AE8C26BB
P2860
Health conditions associated with aging and end of life of adults with Down syndrome
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Health conditions associated with aging and end of life of adults with Down syndrome
@ast
Health conditions associated with aging and end of life of adults with Down syndrome
@en
Health conditions associated with aging and end of life of adults with Down syndrome
@nl
type
label
Health conditions associated with aging and end of life of adults with Down syndrome
@ast
Health conditions associated with aging and end of life of adults with Down syndrome
@en
Health conditions associated with aging and end of life of adults with Down syndrome
@nl
prefLabel
Health conditions associated with aging and end of life of adults with Down syndrome
@ast
Health conditions associated with aging and end of life of adults with Down syndrome
@en
Health conditions associated with aging and end of life of adults with Down syndrome
@nl
P2860
P1476
Health conditions associated with aging and end of life of adults with Down syndrome
@en
P2093
Anna J Esbensen
P2860
P304
P356
10.1016/S0074-7750(10)39004-5
P577
2010-01-01T00:00:00Z